You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
Reports
AABB Smartbrief
Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge. Click here to subscribe.
Updated: 24 min 45 sec ago
FDA launches program to keep public informed about its performance
The FDA has introduced FDA-TRACK, a performance-measure initiative that will gather and examine records of more than 100 prog -More-
Free Case Study
Quality is critical in every healthcare organization and career. ASQ, the leading community of people passionate about quality, is offering you a sneak peek at the value of an ASQ membership. Download this case study to find out how Kaiser Permanente Colorado used quality tools to increase Medicaid revenue by more than $1 million annually.
Categories: Clinical
Experts mull legal implications of tests after needlestick injuries
In most cases, medical staff test incapacitated patients for blood-borne viruses after needlestick injuries, according to a s -More-
Categories: Clinical
September issue of AABB News focuses on advances in pediatric stem cell therapies
The latest issue of AABB News covers some important developments in the rapidly growing field of pediatric cellular therapies -More-
DONOR DEVELOPMENT COORDINATOR
Florida's Blood Centers
Categories: Clinical
Lily Tomlin,American comedian and actress
For fast-acting relief try slowing down. -More-
Categories: Clinical
Justice Department appeals injunction on stem cell research funding
The Justice Department has filed an appeal asking Judge Royce Lamberth to decide by Sept. -More-
Join AABB Now and Get a Bonus!
Membership certainly has its privileges! As a new member, you'll receive AABB membership through the end of 2011. Get discounts on Annual Meetings, distance learning opportunities and the latest publications, gain access to industry information and tools online. GROW your career. Click here to get started today. Applies to new Individual Memberships only.
Categories: Clinical
Clinical studies on West Nile virus drug are under way
The NIH has allotted $50 million for the development of MGAWN1, an experimental treatment for West Nile virus. -More-
Categories: Clinical
Rival blood thinners Xarelto and apixaban yield positive results in studies
Bayer's Xarelto and Bristol-Myers Squibb's apixaban yielded positive data in terms of efficacy and safety, according to studi -More-
Categories: Clinical
Experts report problems with ELISA kits
Blood bank officials in Mumbai, India, said they have been getting incorrect results from ELISA kits used for HIV testing. -More-
Looking for a better blood band?
Typenex's FlexiBlood system improves transfusion safety with barcodes to reduce transcription errors in the laboratory and at the bedside. If your facility isn't scanning barcodes yet, FlexiBlood has numerous benefits over other systems available today. See what blood bankers are saying about FlexiBlood and comparative test data by clicking here.
Categories: Clinical
N.Y. hospital uses text messages to boost teens' drug adherence
A program being launched at NewYork-Presbyterian/Morgan Stanley Children's Hospital aims to send text messages to remind hear -More-
Categories: Clinical
Kentucky hospitals implement program to reduce blood infections
Thirty-nine hospitals in Kentucky have pledged to implement the Comprehensive Unit-based Safety Program, which aims to reduce -More-
Categories: Clinical
Federal grant will back Dynavax's hep B vaccine research
The National Institute of Allergy and Infectious Diseases has awarded part of a five-year, $17.6 million grant to Dynavax Tec -More-
Categories: Clinical
FDA device unit's webcast focuses on 510(k) process overhaul
A webcast from the FDA's Center for Devices and Radiological Health held on Tuesday aimed to address medical-device firms' an -More-
Categories: Clinical
Poll: 45% of Americans view health reform unfavorably
The latest Kaiser Family Foundation survey found that 45% of Americans have an unfavorable view of the health reform law, whi -More-
Categories: Clinical
Health experts caution about the risks of stem cell treatments
A panel of British health experts on Tuesday cautioned about the risks of undergoing unproven stem cell therapy offered in pr -More-
Categories: Clinical
Annual Meeting spotlight: Session to explore pros, cons, how-tos of centralized transfusion service
Experts will explore the advantages and challenges as well as the how-tos of establishing a centralized transfusion service d -More-
Clinical Laboratory Scientist, Referene Lab
Blood Centers of the Pacific
Categories: Clinical
Renata Adler,American author
It is always self-defeating to pretend to the style of a generation younger than your own; it simply erases your own experien -More-
Categories: Clinical
NIH orders internal researchers to stop embryonic stem cell studies
The NIH has ordered the termination of all internal research using human embryonic stem cells in compliance with a court ruli -More-
Collection Set and Volume Changes Can Impact Plasma Yields
Pall's Plasma Optimization Guide reviews WB collection and processing to reveal how choices made by your facility within these processes impact plasma yields. Did you know that the WB collection system used and the volume of WB collected can have a direct effect on the amount of plasma recovered during the component processing steps? Learn more.
Categories: Clinical
Mayo Clinic Florida continues search for at-risk patients
Mayo Clinic Florida said it has teamed up with the state's Department of Health and the CDC in identifying patients who shoul -More-
Categories: Clinical
Study finds HIV can lurk in brain, spinal fluid
Ten percent of 70 HIV-positive patients taking HIV treatments were found by Swedish researchers to have HIV not in the blood, -More-
Categories: Clinical
Novartis prepares for final-stage testing of Portola's elinogrel
Novartis will launch a late-stage study of elinogrel, an anti-clotting drug licensed from Portola Pharmaceuticals, early next -More-
New! Order Immunoglobulin Therapy Today!
Simply put, this text contains all the information you need most about intravenous immunoglobulin (IVIG) products and their use in clinical practice. This collaboration of international experts has resulted in the most comprehensive resource available in an area of transfusion medicine that is rapidly growing. To read more and order your copy, click here.
Categories: Clinical
